An Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy, immunogenicity and safety of EV71 Vaccines in preventing Hand, Foot and Mouth disease caused by EV71 in a total 10,000 healthy infants volunteers aged from 6 to 35months old.

Clinical Trial Description

The phase II study of inactivated vaccine (vero cell) against EV71 has completed on Dec 2011 in China. The data from the phase I and II study suggested that the inactivated EV71 vaccine had a clinically acceptable safety and good immunogenicity for healthy Chinese infants. In order to evaluate the efficacy of the vaccine against Hand, Foot and Mouth disease caused by EV71, and to further explore the safety profile of this vaccine in expending infant population, a phase III clinical trial is planed to conduct. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01507857
Study type	Interventional
Source	Sinovac Biotech Co., Ltd
Contact
Status	Completed
Phase	Phase 3
Start date	January 2012
Completion date	March 2013

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06063057` - Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial	Phase 1/Phase 2
Completed	`NCT04133584` - The Immunogenicity and Safety of the Vaccination of Inactivated Enterovirus 71 Vaccine and Seasonal Influenza Vaccine	Phase 4
Completed	`NCT03241030` - Sucralfate to Improve Oral Intake in Children With Infectious Oral Ulcers: a Randomized, Double-blind, Placebo-Controlled Trial	Phase 2
Completed	`NCT01255124` - Study on Dynamic Changes of the Maternal Anti-EV71 and Anti-CVA16 Antibody Levels in Infants and Young Children	N/A
Completed	`NCT03873740` - Immunogenicity and Safety of Two Different Commercial EV71 Vaccines	Phase 4
Completed	`NCT05637229` - A Serosurvey Study of Hand, Foot, and Mouth Disease in Indonesia
Recruiting	`NCT06146088` - Lot-to-lot Consistency Study of Three Commercial Batches of Enterovirus 71 Vaccine	Phase 4
Active, not recruiting	`NCT06209398` - Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal Vaccine	Phase 4
Recruiting	`NCT01145664` - A Multi-Center Clinical Trial To Evaluate Chinese Herbal Medicines in the Treatment of Severe Hand-foot-mouth Disease	N/A
Recruiting	`NCT01175915` - A Clinical Trial To Evaluate Reduning Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease	N/A
Completed	`NCT01182532` - A Clinical Trial to Evaluate the Effectiveness and Safety of Chinese Medicine in the Treatment of Mild Type of Hand, Foot, and Mouth Disease	N/A
Completed	`NCT03281174` - Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) Vaccine	N/A
Completed	`NCT03582761` - Efficacy Evaluation for Inactivated Vaccine (Vero Cell) Against EV71	Phase 4
Completed	`NCT03903926` - Efficacy Trial of a Commercial EV71 Vaccine	Phase 4
Completed	`NCT02001233` - A Follow-up Study for a Phase III, Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine
Completed	`NCT03909074` - Clinical Trial of Enterovirus 71（EV71） Inactivated Vaccine in Children Aged 36-71 Months	Phase 3
Completed	`NCT01769794` - Chinese Medicinal Treatment on Mild Hand, Foot, and Mouth Disease: Multicenter, Prospective, Randomized Double-blind, Placebo-controlled Study	N/A
Recruiting	`NCT01182025` - A Clinical Trial to Evaluate the Effectiveness and Safety of Xiyanping Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease	N/A
Recruiting	`NCT06263439` - Surveillance of HFMD in Pediatric Outpatients
Not yet recruiting	`NCT05397587` - An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell)	Phase 4